title: [Inhibitory effect of vasoactive intestinal peptide (VIP) and peptide histidine isoleucine (PHI) on bronchoconstriction in guinea pigs].
abstract: The present studies were conducted to investigate whether or not VIP and PHI have a bronchodilator effect in vivo. VIP or PHI was administered intravenously in guinea pigs, and dynamic respiratory resistance was measured. Intravenous administration of VIP and PHI reduced dynamic respiratory resistance; however, the effect was significantly less than that of isoprenaline. VIP and PHI inhibited the increase in dynamic respiratory resistance by intravenous administration of histamine in a dose-dependent manner, suggesting that VIP and PHI may be involved in the pathogenesis of airway hyperresponsiveness through inhibiting the effect of mediators on the airway.
authors: First Department of Internal Medicine, Gunma University School of Medicine, Maebashi, Japan.
authors: S
authors: S
authors: Aoki
authors: M
authors: M
authors: Kurosawa
authors: T
authors: T
authors: Ishizuka
authors: M
authors: M
authors: Mori
mesh_terms: D000403:Airway Resistance / Q000187:drug effects; D000818:Animals; D016084:Bronchoconstriction / Q000187:drug effects*; D006168:Guinea Pigs; D007275:Injections, Intravenous; D008297:Male; D010451:Peptide PHI / Q000008:administration & dosage / Q000494:pharmacology*; D014660:Vasoactive Intestinal Peptide / Q000008:administration & dosage / Q000494:pharmacology*
chemical_list: D010451:Peptide PHI; D014660:Vasoactive Intestinal Peptide